Platinum Investment Management’s Foundation Medicine, Inc. FMI Stock Holding History

Platinum Investment Management’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-21,700	Closed	-$2.97M	–	95
2018 Q2	$2.97M	Sell	21,700 -5,200	-19%	-$472K	0.07%	41
2018 Q1	$2.12M	Sell	26,900 -26,000	-49%	-$1.92M	0.06%	51
2017 Q4	$3.61M	Sell	52,900 -37,800	-42%	-$1.96M	0.1%	41
2017 Q3	$3.65M	Hold	90,700	–	–	0.09%	40
2017 Q2	$3.6M	Sell	90,700 -6,600	-7%	-$242K	0.1%	37
2017 Q1	$3.14M	Sell	97,300 -17,400	-15%	-$434K	0.09%	41
2016 Q4	$2.03M	Sell	114,700 -13,300	-10%	-$287K	0.06%	47
2016 Q3	$2.99M	Hold	128,000	–	–	0.07%	43
2016 Q2	$2.39M	Hold	128,000	–	–	0.06%	49
2016 Q1	$2.33M	Buy	128,000 +73,000	+133%	+$1.18M	0.05%	52
2015 Q4	$1.16M	Buy	+55,000	New	+$1.06M	0.03%	69

Platinum Investment Management's FMI Position: Q3 2018 in Review

Platinum Investment Management sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 21,700 shares — an estimated $2.97M sold.

Platinum Investment Management first reported a position in FMI in Q4 2015 and held it in 11 quarters. The position peaked at $3.65M in Q3 2017. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

Platinum Investment Management reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
Platinum Investment Management sold 21,700 Foundation Medicine, Inc. shares in Q3 2018, an estimated $2.97M.
Platinum Investment Management first reported a position in Foundation Medicine, Inc. in Q4 2015 and held it in 11 quarters.
Platinum Investment Management's Foundation Medicine, Inc. position peaked at $3.65M in Q3 2017.
0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Platinum Investment Management's 13F filing for Q3 2018, filed 15 Nov 2018.